These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27995466)

  • 1. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
    Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
    AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Zhang J; Huang Y; Liu D; Gao Y; Qian S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
    Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.
    Barbosa SF; Takatsuka T; Tavares GD; Araújo GL; Wang H; Vehring R; Löbenberg R; Bou-Chacra NA
    Pharm Dev Technol; 2016 Nov; 21(7):812-822. PubMed ID: 27825283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
    Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
    Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin.
    Guo M; Fu Q; Wu C; Guo Z; Li M; Sun J; He Z; Yang L
    Colloids Surf B Biointerfaces; 2015 Apr; 128():410-418. PubMed ID: 25766921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
    Jain S; Patel K; Arora S; Reddy VA; Dora CP
    Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.
    Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
    Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
    Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.